Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Zolmitriptan 2.5 mg oral tablet |
Is a |
False |
Zolmitriptan product (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing zolmitriptan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zolmitriptan product (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Zolmitriptan 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zolmitriptan product (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely zolmitriptan 5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zolmitriptan product (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Zolmitriptan zmt 2.5mg disintegrating tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zolmitriptan product (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Zolmitriptan 2.5mg oro-dispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zolmitriptan product (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Zomig 5mg nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zolmitriptan product (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Zolmitriptan 5mg nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zolmitriptan product (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Zolmitriptan 2.5 mg orodispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zolmitriptan product (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Zolmitriptan 5 mg orodispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zolmitriptan product (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Zolmitriptan-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zolmitriptan product (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Zolmitriptan-containing product in nasal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zolmitriptan product (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Zolmitriptan 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zolmitriptan product (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Zolmitriptan 2.5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Zolmitriptan product (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely zolmitriptan 5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zolmitriptan product (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely zolmitriptan 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Zolmitriptan product (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Zolmitriptan 2.5 mg oral tablet |
Has precise active ingredient |
True |
Zolmitriptan product (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely zolmitriptan 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Zolmitriptan product (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only zolmitriptan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zolmitriptan product (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Zolmitriptan only product in nasal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zolmitriptan product (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only zolmitriptan in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zolmitriptan product (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Zolmitriptan 5 mg orodispersible tablet |
Has basis of strength substance (attribute) |
True |
Zolmitriptan product (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Zolmitriptan 5 mg orodispersible tablet |
Has precise active ingredient |
True |
Zolmitriptan product (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Zolmitriptan 2.5 mg orodispersible tablet |
Has precise active ingredient |
True |
Zolmitriptan product (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Zolmitriptan 2.5 mg orodispersible tablet |
Has basis of strength substance (attribute) |
True |
Zolmitriptan product (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely zolmitriptan 5 milligram/1 actuation conventional release nasal spray (clinical drug) |
Has basis of strength substance (attribute) |
True |
Zolmitriptan product (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely zolmitriptan 5 milligram/1 actuation conventional release nasal spray (clinical drug) |
Has precise active ingredient |
True |
Zolmitriptan product (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing zolmitriptan in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zolmitriptan product (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Zolmitriptan only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zolmitriptan product (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |